Drake Lorin 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 25, 2013
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Award
Stock Option to Buy
2013-02-21+8,499→ 8,499 totalExercise: $16.45Exp: 2023-02-21→ Common Stock (8,499 underlying) - Award
Common Stock
2013-02-21+4,924→ 22,478 total
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 21, 2014.